Nanoparticles (NPs) can make their way to the brain and cause in situ damage, which is a
concern for nanomaterial application and airborne particulate matter exposure. Our recent …

The recent development of RNA‐based therapeutics in delivering nucleic acids for gene
editing and regulating protein translation has led to the effective treatment of various …

Nanoparticles (NPs) are currently developed for drug delivery and molecular imaging.
However, they often get intercepted before reaching their target, leading to low targeting …

Acute liver failure (ALF) is a life‐threatening disease associated with the rapid development
of inflammatory storms, level elevation of reactive oxygen species (ROS), and hepatocyte …

Iron oxide nanoparticles (IONPs) possess unique magnetism and good biocompatibility, and
they have been widely applied as contrast agents (CAs) for magnetic resonance imaging …

Liver fibrosis could be the last hope for treating liver cancer and remodeling of the hepatic
microenvironment has emerged as a strategy to promote the ablation of liver fibrosis. In …

Nickel nanoparticles (NiNPs) have wide applications in industry and biomedicine due to
their unique characteristics. The liver is the major organ responsible for nutrient metabolism …

The existing diagnosis and treatment modalities have major limitations related to their
precision and capability to understand several stages of disease development. A superior …

Liver fibrosis is a process of excessive accumulation of extracellular matrix caused by liver
injury. Liver fibrosis can progress to cirrhosis or even liver cancer without proper …

Proteolysis targeting chimeras (PROTAC) are an emerging precision medicine strategy,
which targets key proteins for proteolytic degradation to ultimately induce cancer cell killing …